5.46
price up icon2.23%   0.08
after-market アフターアワーズ: 5.46
loading

Immucell Corp (ICCC) 最新ニュース

pulisher
Apr 17, 2025

The Zacks Analyst Blog Netflix, SAP SE, Shell, Preformed Line Products and ImmuCell - Yahoo Finance

Apr 17, 2025
pulisher
Apr 16, 2025

ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving Average – What’s Next? - Defense World

Apr 16, 2025
pulisher
Apr 08, 2025

ImmuCell reports record sales in first quarter of 2025 - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Record Quarter: ImmuCell Crushes Sales Estimates with $8.1M Revenue Milestone - Stock Titan

Apr 08, 2025
pulisher
Apr 07, 2025

ImmuCell appoints new CFO to bolster growth strategy - Investing.com

Apr 07, 2025
pulisher
Apr 07, 2025

ImmuCell Strengthens Leadership: 24-Year IDEXX Finance Expert Takes CFO Role - Stock Titan

Apr 07, 2025
pulisher
Apr 03, 2025

ImmuCell Full Year 2024 Earnings: US$0.26 loss per share (vs US$0.74 loss in FY 2023) - Yahoo Finance

Apr 03, 2025
pulisher
Apr 02, 2025

Revolutionary Antibiotic-Free Mastitis Treatment Enters Market Testing Phase - Stock Titan

Apr 02, 2025
pulisher
Mar 28, 2025

IMMUCELL CORP /DE/ SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 26, 2025

ImmuCell (NASDAQ:ICCC) Stock Passes Above 200 Day Moving Average – Time to Sell? - Defense World

Mar 26, 2025
pulisher
Mar 18, 2025

ImmuCell (NASDAQ:ICCC) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World

Mar 18, 2025
pulisher
Feb 28, 2025

ImmuCell Corp. to Host Earnings Call - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

ImmuCell Posts Y/Y Q4 Earnings Growth, Awaits FDA Approval For Re-Tain - Barchart

Feb 28, 2025
pulisher
Feb 27, 2025

ImmuCell Corp (ICCC) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Operational ... By GuruFocus - Investing.com Canada

Feb 27, 2025
pulisher
Feb 26, 2025

ImmuCell Corporation (NASDAQ:ICCC) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings call transcript: ImmuCell sees strong Q4 2024 sales growth - Investing.com

Feb 26, 2025
pulisher
Feb 25, 2025

ImmuCell Corporation Reports Strong Financial Performance for Q4 and Full Year 2024 - TradingView

Feb 25, 2025
pulisher
Feb 20, 2025

Animal Health Pioneer ImmuCell Sets Stage for Critical Year-End Financial Reveal - StockTitan

Feb 20, 2025
pulisher
Feb 18, 2025

The Zacks Analyst Blog Highlights Apple, Eli Lilly, Shopify and ImmuCell - Yahoo Finance

Feb 18, 2025
pulisher
Feb 14, 2025

Top Stock Reports for Apple, Eli Lilly & Shopify - Yahoo Finance

Feb 14, 2025
pulisher
Feb 12, 2025

ImmuCell (NASDAQ:ICCC) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World

Feb 12, 2025
pulisher
Feb 10, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Feb 10, 2025
pulisher
Feb 04, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Feb 04, 2025
pulisher
Jan 25, 2025

ImmuCell (NASDAQ:ICCC) Stock Passes Above 200 Day Moving Average – What’s Next? - Defense World

Jan 25, 2025
pulisher
Jan 19, 2025

ImmuCell Settles Insurance Claim for Production Contamination Events - Defense World

Jan 19, 2025
pulisher
Jan 16, 2025

ImmuCell settles insurance claim for production losses - Investing.com

Jan 16, 2025
pulisher
Jan 16, 2025

ImmuCell Secures $426,587 Additional Insurance Settlement for Production Contamination Issues - StockTitan

Jan 16, 2025
pulisher
Jan 13, 2025

ImmuCell Announces Strong Preliminary Sales Results for Q4 and Full Year 2024 - Defense World

Jan 13, 2025
pulisher
Jan 09, 2025

ImmuCell Sales Surge 52% to Record $26.5M as Production Hits Full Capacity - StockTitan

Jan 09, 2025
pulisher
Dec 21, 2024

ImmuCell (NASDAQ:ICCC) Shares Pass Above 200 Day Moving Average – Here’s What Happened - Defense World

Dec 21, 2024
pulisher
Dec 10, 2024

ImmuCell announces executive transition with part-time agreement By Investing.com - Investing.com South Africa

Dec 10, 2024
pulisher
Dec 09, 2024

ImmuCell announces executive transition with part-time agreement - Investing.com

Dec 09, 2024
pulisher
Dec 04, 2024

Zacks Initiates Coverage of ImmuCell With Neutral Recommendation - Yahoo Finance

Dec 04, 2024
pulisher
Dec 04, 2024

The Zacks Analyst Blog Highlights Amazon.com, Stryker, Lam Research and ImmuCell - Yahoo Finance

Dec 04, 2024
pulisher
Dec 03, 2024

Top Research Reports for Amazon, Stryker & Lam Research - Yahoo Finance

Dec 03, 2024
pulisher
Dec 02, 2024

ImmuCell amends agreement with Norbrook Labs - Investing.com

Dec 02, 2024
pulisher
Nov 20, 2024

ImmuCell Q3 Earnings Decline Y/Y, Sales Grow Amid Margin Challenges - MSN

Nov 20, 2024
pulisher
Nov 16, 2024

ImmuCell Third Quarter 2024 Earnings: US$0.086 loss per share (vs US$0.12 loss in 3Q 2023) - Yahoo Finance

Nov 16, 2024
pulisher
Nov 15, 2024

ImmuCell Corporation (NASDAQ:ICCC) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 14, 2024

Earnings call: ImmuCell reports recovery and strong demand for Q3 2024 - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

ICCCImmucell Corp Latest Stock News & Market Updates - StockTitan

Nov 14, 2024
pulisher
Nov 13, 2024

ImmuCell Q3 Sales Jump 11% to $6M, Nine-Month Revenue Surges 51% Despite Net Loss | ICCC Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 07, 2024

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 - StockTitan

Nov 07, 2024
pulisher
Oct 08, 2024

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024 - StockTitan

Oct 08, 2024
pulisher
Aug 16, 2024

ImmuCell Second Quarter 2024 Earnings: US$0.20 loss per share (vs US$0.18 loss in 2Q 2023) - Yahoo Finance

Aug 16, 2024
pulisher
Aug 13, 2024

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024 - StockTitan

Aug 13, 2024
pulisher
Aug 07, 2024

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 - StockTitan

Aug 07, 2024
pulisher
Jul 10, 2024

PriceSmart, Kura Sushi And 3 Stocks To Watch Heading Into Wednesday - Benzinga

Jul 10, 2024
pulisher
Jul 09, 2024

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 - StockTitan

Jul 09, 2024
$20.27
price up icon 0.92%
$71.24
price up icon 2.53%
$32.19
price up icon 0.11%
$27.35
price up icon 8.52%
$104.68
price up icon 2.82%
biotechnology ONC
$252.77
price up icon 10.52%
大文字化:     |  ボリューム (24 時間):